Federal Circuit asked to revamp inequitable conduct standard
Pharmaceutical and technology companies have urged the Court of Appeals for the Federal Circuit to raise the threshold for proving inequitable conduct in patent cases
Drug maker Eisai, Verizon Communications, the IP Owners Association (IPO) and the International Bar Association (ABA) have all filed amicus briefs in the case of Therasense v Becton Dickinson, which the CAFC agreed to hear en banc in April this...
Please log in
to read the rest of this article. New to Managing Intellectual Property?
Take advantage of free access to up to 5 articles on Managing IP and become a member today. It’s free to join and the benefits start straight away.
Please make sure you log in to read the rest of the article.
Join us nowGain FREE access to up to five free articles when you register now.